News headlines about Mazor Robotics (NASDAQ:MZOR) have been trending somewhat positive this week, Accern Sentiment Analysis reports. The research group identifies positive and negative press coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Mazor Robotics earned a media sentiment score of 0.19 on Accern’s scale. Accern also gave headlines about the medical instruments supplier an impact score of 45.6980796560647 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.
Mazor Robotics (NASDAQ:MZOR) opened at $62.11 on Monday. Mazor Robotics has a twelve month low of $20.50 and a twelve month high of $65.97.
MZOR has been the subject of a number of recent research reports. Barclays PLC lowered Mazor Robotics from an “equal weight” rating to an “underweight” rating and reduced their price objective for the company from $55.00 to $34.00 in a research note on Thursday, October 19th. Needham & Company LLC reiterated a “hold” rating on shares of Mazor Robotics in a research note on Wednesday, August 30th. TheStreet upgraded Mazor Robotics from a “d” rating to a “c-” rating in a research note on Wednesday, November 8th. Ladenburg Thalmann Financial Services set a $54.00 price objective on Mazor Robotics and gave the company a “buy” rating in a research note on Wednesday, August 30th. Finally, Zacks Investment Research cut Mazor Robotics from a “strong-buy” rating to a “hold” rating in a research report on Friday, October 13th. Two investment analysts have rated the stock with a sell rating, seven have issued a hold rating and one has assigned a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus price target of $39.83.
TRADEMARK VIOLATION WARNING: “Mazor Robotics (MZOR) Given Media Sentiment Rating of 0.19” was originally published by Transcript Daily and is owned by of Transcript Daily. If you are accessing this article on another domain, it was stolen and republished in violation of US & international copyright law. The correct version of this article can be viewed at https://transcriptdaily.com/2017/11/27/mazor-robotics-mzor-given-media-sentiment-rating-of-0-19.html.
Mazor Robotics Company Profile
Mazor Robotics Ltd is an Israel-based medical device company that develops and markets surgical guidance systems and complementary products. It develops computerized and imaging-based systems in the field of spine surgery. Its products include: Renaissance Surgical Guidance System, which enables surgeons to advance from freehand surgical procedures to guided procedures, as well as Food and Drug Administration (FDA)-cleared and European Conformity (CE)-marked Renaissance System, used in spine surgeries, whether open or minimally invasive, for a number of clinical indications.
Receive News & Ratings for Mazor Robotics Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mazor Robotics Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.